MIRROR MOVEMENTS 4
|
0.400 |
CausalMutation
|
disease |
CLINVAR |
|
|
|
Mirror movements disorder
|
0.110 |
Biomarker
|
disease |
HPO |
|
|
|
Cerebral Palsy
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Mild Mental Retardation
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Agenesis of corpus callosum
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Myalgia
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Clumsiness
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Hypogonadotropic hypogonadism
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Easy fatigability
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Poor fine motor coordination
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Fused cervical vertebrae
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Abnormality of the corticospinal tract
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Specific learning disability
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Dysgenesis of the hippocampus
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Carcinogenesis
|
0.100 |
Biomarker
|
phenotype |
BEFREE |
Inactivation of the murine Dcc gene caused defects in axonal projections that are similar to those observed in netrin-1-deficient mice but did not affect growth, differentiation, morphogenesis or tumorigenesis in mouse intestine.
|
9126737 |
1997 |
Neuroblastoma
|
0.030 |
AlteredExpression
|
disease |
BEFREE |
NTN1L transcripts were detected in essentially all normal adult tissues studied, and markedly reduced or absent NTN1L expression was seen in approximately 50% of brain tumors and neuroblastomas.
|
9950216 |
1999 |
Brain Neoplasms
|
0.010 |
AlteredExpression
|
group |
BEFREE |
NTN1L transcripts were detected in essentially all normal adult tissues studied, and markedly reduced or absent NTN1L expression was seen in approximately 50% of brain tumors and neuroblastomas.
|
9950216 |
1999 |
Neoplasms
|
0.100 |
GeneticVariation
|
group |
BEFREE |
A controversial candidate tumor-suppressor gene at 18q21.2 is DCC (deleted in colorectal carcinoma), which encodes a netrin-1 receptor component with functions in cell migration and apoptosis.
|
10719364 |
2000 |
Neoplasms
|
0.100 |
Biomarker
|
group |
BEFREE |
Hence, UNC5H1, UNC5H2, and UNC5H3 receptors may represent tumor suppressors that inhibit tumor extension outside the region of netrin-1 availability by inducing apoptosis.
|
12655055 |
2003 |
Malignant Neoplasms
|
0.100 |
AlteredExpression
|
group |
BEFREE |
Restored DCC expression in the cancer cell lines in the absence of netrin-1 induced apoptosis.
|
15491747 |
2004 |
Carcinogenesis
|
0.100 |
AlteredExpression
|
phenotype |
BEFREE |
Expression of DCC and netrin-1 in normal human endometrium and its implication in endometrial carcinogenesis.
|
15491747 |
2004 |
Carcinogenesis
|
0.100 |
Biomarker
|
phenotype |
BEFREE |
At first glance, the established role of DCC and netrin-1 during organization of the spinal cord could be viewed as a further challenge to the position that DCC inactivation might play a significant role in tumorigenesis.
|
15310786 |
2004 |
Carcinogenesis
|
0.100 |
Biomarker
|
phenotype |
BEFREE |
So, the netrin-1 receptor pathways probably play an important part in tumorigenesis.
|
15573119 |
2004 |
Primary malignant neoplasm
|
0.100 |
AlteredExpression
|
group |
BEFREE |
Restored DCC expression in the cancer cell lines in the absence of netrin-1 induced apoptosis.
|
15491747 |
2004 |
Malignant neoplasm of endometrium
|
0.010 |
Biomarker
|
disease |
BEFREE |
To define these roles more clearly, we examined the expression of DCC and its ligand, netrin-1, in the normal endometrium and in endometrial cancer.
|
15491747 |
2004 |